Bruno García del Blanco

Showing 1-8 of 8 articles

Coronary interventions

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Okkels Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Pérez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Flensted Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Coronary interventions

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gómez-Hospital J, Sabaté M

December 4, 2020 | 10.4244/EIJ-D-20-00198

Coronary interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial

Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I

December 20, 2019 | 10.4244/EIJ-D-19-00206

Coronary interventions

Spain: coronary and structural heart interventions from 2010 to 2015

García del Blanco B, Jimenez-Quevedo P, Diaz J, Hernandez F, Rumoroso J-R, Sabaté M, de la Torre Hernandez J, Serrador A, Pérez de Prado A, Goicolea J, Trillo R, Pan M

May 15, 2017 | 10.4244/EIJ-D-16-00834

Coronary interventions

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

Garcia-Touchard A, Goicolea J, Sabaté M, Alfonso F, Ruiz-Salmeron R, Bethencourt A, Gonzalo N, Miranda F, García del Blanco B, Jimenez Mazuecos J, Melgares R, Martinez-Romero P, Hernandez-Garcia J, Lezaun R, Bullones J, Fernandez-Portales J, Rumoroso J-R, Ortas R, Valdes M, Trillo R, Brugaletta S, Otzuki S, Hernández Pérez FJ, Alonso-Pulpón L

January 20, 2017 | 10.4244/EIJ-D-16-00128

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

Alfonso F, Pérez-Vizcayno M, Cardenas A, García del Blanco B, García Touchard A, Lopez-Minguez J, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernandez Ortiz A, Escaned J, Jimenez-Quevedo P, Gonzalo N, Fernandez C, Macaya C

July 20, 2015 | 10.4244/EIJY14M09_07

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Costa R, Abizaid A, Abizaid An, García del Blanco B, Berland J, Petrov I, Brenot P, van Geuns R, Royer T, Rubino P, Lesiak M, Fajadet J

March 21, 2012 | 10.4244/EIJV7I11A205

Clinical and procedural evaluation of the Nile Croco® dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients

García del Blanco B, Martí G, Bellera N, Otaegui I, Serra V, Ferreira I, Domingo E, Angel J, Candell J, García-Dorado D

June 30, 2011 | 10.4244/EIJV7I2A36

1

Latest news

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

Fabien Praz et al.

November 19, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)

Patrick W. Serruys

November 23, 2021

Crush techniques for percutaneous coronary intervention of bifurcation lesions

Francesco Moroni et al.

November 18, 2021

Valvular disease